Susan Hasty, Publisher
Table of Contents . . . May 24th, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Drug Week | Other Publications
AIDS and HIV Therapy - Cannabinoids have little impact on protease inhibitor levels
Transplant Medicine - Drug reduces risk of acute rejection in kidney transplantation
AIDS and HIV Therapy - Protease inhibitors affect statin pharmacokinetics
Epilepsy - Anticonvulsant drugs found to impact children's ability to recall information
Hepatitis C - Clinical trials of Civacir commence
Parkinson Disease - Final phase II GPI 1485 imaging data show drug may retard disease progression
AIDS Therapy - 24-week results from phase III study of fusion inhibitor T-20 announced
AIDS-related Cancer - Rituximab potentiates cisplatin effects by Bcl-2 suppression
Abortion - FDA needs to get tougher on RU-486, FRC Says
Antibiotic Resistance - Researchers find high frequency of erythromycin resistance in school children with strep throat
Cytomegalovirus Retinitis - New oral medication halts blindness in AIDS patients
Depression - New Paxil CR now available
Drug Delivery - PEG technology licensed to Zycos for drug-delivery research
Influenza - First phase III clinical trial of Peramivir completed
Menopause - Conflicting information causes confusion about hormone replacement therapy
Multiple Sclerosis - EVIDENCE study confirms that patients on Rebif are more likely to remain relapse free than patients on Avonex
Multiple Sclerosis - Study shows long-term benefit of Copaxone on relapses and neurologic status
Neutropenia - Preliminary data on drugs to treat chemotherapy-induced neutropenia released
Prostate Cancer - Oncolytics Biotech starts first patient treatment in Reolysin trial
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.